Sponsored by IMI
06 Nov 2017

IMI project identifies hits for a new drug target involved in depression and pain

Scientists from IMI’s European Lead Factory (ELF) project have identified novel small molecules that could be transformed into a new medical treatment for depression and pain. The promising compounds will now be further developed by the consortium. The discovery is important as many patients with depression and pain do not respond to current treatments.